Showing 601-610 of 867 results for "".
BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianRosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Dermatologists Give AI A Thumbs Up
https://practicaldermatology.com/topics/practice-management/dermatologists-give-ai-a-thumbs-up/23673/Dr. Vishal Patel talks augmented intelligence and how it may change practice.One-and-Done Tattoo Removal: Is It Possible With Q-switched Technology?
https://practicaldermatology.com/topics/practice-management/one-and-done-tattoo-removal-is-it-possible-with-q-switched-technology/21019/Newer and more powerful nanosecond lasers coupled with improved techniques have greatly improved the ability to clear tattoos faster and treat resistant colors.It’s A Hit! CSF Takes to Music City
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/its-a-hit-csf-takes-to-music-city/23199/If you weren’t at the meeting in Nashville, here’s what you missed.Understanding a New Method of Assessing Psoriasis Severity
https://practicaldermatology.com/columns/clinical-focus-1/understanding-a-new-method-of-assessing-psoriasis-severity/23157/New method aims to improve access to systemic psoriasis therapy.Physician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-steven-r-feldman-md-phd/20541/The new thinking on improving adherence in dermatology.Upadacitinib and Cardiovascular Events in AD
https://practicaldermatology.com/issues/october-2025/upadacitinib-and-cardiovascular-events-in-ad/39755/A recent review examined whether upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor approved for atopic dermatitis (AD) and other chronic inflammatory diseases, may—despite a boxed warning to the contrary—confer cardioprotective and thromboprotective effects.EBDs, CBD, Millennials, and More in the Mix at CSF
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/ebds-cbd-millennials-and-more-in-the-mix-at-csf/23131/Get the scoop on what will happen live at CSF 2019!Expectations: Put it in Writing
https://practicaldermatology.com/topics/practice-management/expectations-put-it-in-writing/20521/Patients who have clear expectations and understand their role in their care and treatment are more engaged, more compliant, and are more likely to have better outcomes. It helps to get it in writing.